KOHIMA, JULY 1: Nagaland reported more COVID-19 recoveries than detection of fresh infection for the 4th consecutive day today, as 82 patients recuperated while 66 new cases increased tally to 25,305.
“66 positive cases detected today are Mokokchung: 20, Kohima: 13, Dimapur: 11, Peren: 10, Phek: 5, Wokha: 3, Kiphire: 2 and Mon & Tuensang: 1 each,” said State Nodal Officer for Integrated Disease Surveillance Project, Dr Nyanthung Kikon in the daily COVID-19 bulletin.
He also said that 82 positive patients ~ Kohima: 24, Dimapur & Mokokchung: 19 each, Zunheboto: 9, Peren: 7 and Wokha: 4 ~ recovered during the day increasing the number of recovered patients to 22,781.
This has slightly improved the recovery rate to 90.03% from Wednesday’s 89.93%.
The caseload includes 1,321 active patients, of which, 130 are with mild symptoms, 29 are moderate on oxygen, 6 severe on oxygen, 3 critical in ICU without ventilator and 8 on ventilator, while 1,145 patients are asymptomatic, he said.
Demise of 3 positive patients – 1 each at Mokokchung, Mon and Wokha districts has increased the death toll in the State to 498, of which 14 patients had co-morbidities, he said.
Altogether 705 COVID-19 patients have migrated to other States, he said.
So far, a total of 2,27,838 suspected COVID-19 samples have been tested in Nagaland. It includes 97,890 on RT-PCR, 61,905 on TrueNat, and 68,043 on Rapid Antigen Test, said Dr Kikon.
Nagaland has crossed the 5 lakh mark of administering COVID-19 vaccine.
As on Wednesday, a total of 5,08,393 doses of COVID-19 vaccines were administered to 4,46,094 persons, said State Immunization Officer Dr Ritu Thurr.
Out of the total doses administered in the State, 60,155 are frontline workers, 15,804 are healthcare professionals, 1,51,819 are people above 45 years and 2,18,316 in the 18 to 44 years age group, he said.
A total of 62,299 beneficiaries have received the second dose of the vaccine completing the full course of vaccination. They comprise 29,095 frontline workers, 10,554 healthcare workers, 22,698 people above 45 years and 12 in the 18 to 44 years age group, said Dr Thurr.
(Page News Service)